Fellowship · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Nature · 2021 · 1,859 citations · James Casella
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Robbie Majzner
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
European journal of nuclear medicine and molecular imaging · 2023 · 338 citations · Steve Cho
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature · 2025 · 172 citations · Robbie Majzner
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours.
Nature reviews. Clinical oncology · 2023 · 463 citations · Robbie Majzner
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Nature medicine · 2021 · 534 citations · Robbie Majzner
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.
Journal of hepatology · 2025 · 91 citations · Robyn Gartrell
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.
The New England journal of medicine · 2023 · 262 citations · Kenneth Cohen